Loading insider details...
Beta
Latest Form 4 (Oct 5, 2026): Exercise/Conversion of 37,500 ALT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 5, 2026 | Altimmune, Inc. (ALT) | Exercise/Conversion | 37,500 | n/a |
| Oct 3, 2025 | Altimmune, Inc. (ALT) | Grant/Award | 450,000 | n/a |
| Feb 14, 2025 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 850,000 | n/a |
| Jan 27, 2025 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 25,831 | n/a |
| Feb 16, 2024 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 475,831 | n/a |
| Sep 5, 2023 | X4 Pharmaceuticals, Inc (XFOR) | Grant/Award | 1,250,000 | $1.60M |
| May 28, 2020 | Millendo Therapeutics, Inc. (MLND) | Grant/Award | 80,000 | n/a |
| Feb 11, 2020 | Millendo Therapeutics, Inc. (MLND) | Grant/Award | 140,000 | n/a |